Developing an AI algorithm to predict immunotherapy response
Learn how Tempus developed a novel immune profile score (IPS) by analyzing multimodal de-identified data from over 1,700 patients to better predict immunotherapy response and identify more potential responders than standard biomarkers.
Jul 28, 2026
Life Sciences
Case Study
Related content


